Concepts (160)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Extracorporeal Membrane Oxygenation | 12 | 2024 | 655 | 2.390 |
Why?
|
| Critical Illness | 11 | 2024 | 618 | 1.670 |
Why?
|
| Hemorrhage | 6 | 2024 | 519 | 1.340 |
Why?
|
| Platelet Transfusion | 5 | 2020 | 56 | 1.180 |
Why?
|
| Thrombelastography | 3 | 2026 | 63 | 1.130 |
Why?
|
| Anticoagulants | 8 | 2024 | 609 | 1.030 |
Why?
|
| Thrombosis | 4 | 2024 | 524 | 1.010 |
Why?
|
| Blood Loss, Surgical | 1 | 2026 | 159 | 0.890 |
Why?
|
| Postoperative Care | 2 | 2019 | 312 | 0.820 |
Why?
|
| Delphi Technique | 4 | 2024 | 240 | 0.780 |
Why?
|
| Thrombophilia | 1 | 2021 | 41 | 0.710 |
Why?
|
| Blood Preservation | 2 | 2019 | 30 | 0.670 |
Why?
|
| Blood Coagulation Disorders | 1 | 2021 | 109 | 0.670 |
Why?
|
| Nervous System Diseases | 1 | 2024 | 408 | 0.660 |
Why?
|
| Erythrocyte Transfusion | 1 | 2019 | 138 | 0.570 |
Why?
|
| Blalock-Taussig Procedure | 1 | 2019 | 49 | 0.570 |
Why?
|
| Multiple Organ Failure | 1 | 2019 | 144 | 0.570 |
Why?
|
| Aspirin | 1 | 2019 | 220 | 0.530 |
Why?
|
| Infant | 17 | 2026 | 13047 | 0.530 |
Why?
|
| Liver Transplantation | 1 | 2026 | 1102 | 0.520 |
Why?
|
| Child, Preschool | 17 | 2026 | 14732 | 0.510 |
Why?
|
| Child | 23 | 2026 | 25762 | 0.500 |
Why?
|
| Blood Coagulation Tests | 3 | 2026 | 61 | 0.470 |
Why?
|
| Infant, Newborn | 13 | 2024 | 8542 | 0.450 |
Why?
|
| Drug Monitoring | 2 | 2024 | 174 | 0.450 |
Why?
|
| Severity of Illness Index | 2 | 2024 | 3089 | 0.440 |
Why?
|
| Escherichia coli O157 | 1 | 2014 | 6 | 0.440 |
Why?
|
| Hemolytic-Uremic Syndrome | 1 | 2014 | 35 | 0.430 |
Why?
|
| Intensive Care Units, Pediatric | 5 | 2023 | 466 | 0.410 |
Why?
|
| Sepsis | 3 | 2024 | 515 | 0.400 |
Why?
|
| Abdomen, Acute | 1 | 2013 | 14 | 0.390 |
Why?
|
| Critical Care | 1 | 2018 | 686 | 0.390 |
Why?
|
| Acidosis, Renal Tubular | 1 | 2012 | 6 | 0.380 |
Why?
|
| Status Epilepticus | 1 | 2014 | 157 | 0.380 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2018 | 767 | 0.370 |
Why?
|
| Escherichia coli Infections | 1 | 2014 | 192 | 0.370 |
Why?
|
| Vomiting | 1 | 2013 | 108 | 0.370 |
Why?
|
| Hypercalcemia | 1 | 2012 | 42 | 0.370 |
Why?
|
| Cough | 1 | 2013 | 96 | 0.370 |
Why?
|
| Hyperammonemia | 1 | 2012 | 62 | 0.360 |
Why?
|
| Water-Electrolyte Balance | 1 | 2011 | 82 | 0.360 |
Why?
|
| Precision Medicine | 1 | 2014 | 360 | 0.340 |
Why?
|
| Heart Septal Defects, Ventricular | 1 | 2011 | 133 | 0.340 |
Why?
|
| Heart Septal Defects, Atrial | 1 | 2011 | 123 | 0.330 |
Why?
|
| Evidence-Based Medicine | 1 | 2014 | 662 | 0.330 |
Why?
|
| Heart Defects, Congenital | 2 | 2019 | 1861 | 0.330 |
Why?
|
| Angiolymphoid Hyperplasia with Eosinophilia | 1 | 2009 | 4 | 0.310 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2014 | 551 | 0.310 |
Why?
|
| Humans | 35 | 2026 | 131985 | 0.310 |
Why?
|
| Hemostasis | 3 | 2022 | 73 | 0.290 |
Why?
|
| Hemostatics | 2 | 2022 | 62 | 0.290 |
Why?
|
| Male | 18 | 2026 | 64910 | 0.290 |
Why?
|
| International Normalized Ratio | 2 | 2026 | 43 | 0.280 |
Why?
|
| beta-Thalassemia | 1 | 2007 | 27 | 0.260 |
Why?
|
| Platelet Count | 4 | 2020 | 139 | 0.260 |
Why?
|
| Postoperative Complications | 1 | 2019 | 3142 | 0.250 |
Why?
|
| Retrospective Studies | 7 | 2026 | 17391 | 0.250 |
Why?
|
| Female | 16 | 2026 | 70623 | 0.240 |
Why?
|
| Adolescent | 10 | 2026 | 20535 | 0.230 |
Why?
|
| Pediatrics | 1 | 2014 | 1211 | 0.220 |
Why?
|
| Thrombin | 2 | 2022 | 60 | 0.220 |
Why?
|
| Administration, Oral | 2 | 2019 | 698 | 0.220 |
Why?
|
| Treatment Outcome | 5 | 2024 | 13019 | 0.200 |
Why?
|
| Hospital Mortality | 4 | 2023 | 1057 | 0.200 |
Why?
|
| Thromboembolism | 1 | 2022 | 93 | 0.170 |
Why?
|
| Consensus | 4 | 2024 | 649 | 0.170 |
Why?
|
| Practice Guidelines as Topic | 2 | 2020 | 1301 | 0.170 |
Why?
|
| Disease Progression | 2 | 2019 | 2222 | 0.160 |
Why?
|
| Predictive Value of Tests | 1 | 2026 | 2317 | 0.160 |
Why?
|
| Patient Acuity | 1 | 2019 | 67 | 0.160 |
Why?
|
| Calcium Chloride | 1 | 2019 | 23 | 0.150 |
Why?
|
| Mental Disorders | 1 | 2007 | 888 | 0.150 |
Why?
|
| Anemia, Sickle Cell | 1 | 2023 | 328 | 0.150 |
Why?
|
| Arginine Vasopressin | 1 | 2019 | 28 | 0.150 |
Why?
|
| Blood Grouping and Crossmatching | 1 | 2019 | 16 | 0.150 |
Why?
|
| Blood Coagulation | 2 | 2023 | 130 | 0.150 |
Why?
|
| Respiratory Distress Syndrome, Newborn | 1 | 2019 | 83 | 0.150 |
Why?
|
| Tennessee | 1 | 2018 | 35 | 0.150 |
Why?
|
| Leukocyte Reduction Procedures | 1 | 2018 | 3 | 0.150 |
Why?
|
| Vasoconstrictor Agents | 1 | 2019 | 141 | 0.140 |
Why?
|
| Echocardiography, Doppler | 1 | 2019 | 172 | 0.140 |
Why?
|
| Acute Disease | 2 | 2020 | 1160 | 0.140 |
Why?
|
| Pandemics | 2 | 2024 | 1183 | 0.140 |
Why?
|
| Blood Transfusion | 1 | 2020 | 291 | 0.140 |
Why?
|
| Aging, Premature | 1 | 2017 | 28 | 0.140 |
Why?
|
| Glial Cell Line-Derived Neurotrophic Factor | 1 | 2017 | 24 | 0.140 |
Why?
|
| Computed Tomography Angiography | 1 | 2019 | 215 | 0.130 |
Why?
|
| Diagnosis, Differential | 3 | 2013 | 1951 | 0.130 |
Why?
|
| Logistic Models | 2 | 2020 | 1839 | 0.130 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2019 | 1132 | 0.130 |
Why?
|
| Fetal Blood | 1 | 2017 | 170 | 0.130 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2019 | 289 | 0.130 |
Why?
|
| Chronic Disease | 1 | 2020 | 1233 | 0.120 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2019 | 1672 | 0.110 |
Why?
|
| Stroke | 1 | 2023 | 1084 | 0.110 |
Why?
|
| Baseball | 1 | 2014 | 6 | 0.110 |
Why?
|
| Coronary Aneurysm | 1 | 2014 | 33 | 0.110 |
Why?
|
| Thoracic Injuries | 1 | 2014 | 90 | 0.100 |
Why?
|
| Prospective Studies | 6 | 2022 | 6569 | 0.100 |
Why?
|
| Gestational Age | 1 | 2017 | 1224 | 0.100 |
Why?
|
| Fatal Outcome | 1 | 2014 | 370 | 0.100 |
Why?
|
| Hydronephrosis | 1 | 2013 | 37 | 0.100 |
Why?
|
| Hernia, Diaphragmatic | 1 | 2013 | 99 | 0.100 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2014 | 221 | 0.090 |
Why?
|
| Ascariasis | 1 | 2013 | 73 | 0.090 |
Why?
|
| Peritoneal Cavity | 1 | 2011 | 20 | 0.090 |
Why?
|
| Ureteral Obstruction | 1 | 2013 | 105 | 0.090 |
Why?
|
| Heparin | 2 | 2023 | 212 | 0.090 |
Why?
|
| Anthropometry | 1 | 2011 | 194 | 0.090 |
Why?
|
| Prognosis | 2 | 2019 | 5008 | 0.090 |
Why?
|
| Fluid Therapy | 1 | 2011 | 147 | 0.080 |
Why?
|
| Acalculous Cholecystitis | 1 | 2010 | 1 | 0.080 |
Why?
|
| Drainage | 1 | 2011 | 263 | 0.080 |
Why?
|
| Cholecystitis, Acute | 1 | 2010 | 17 | 0.080 |
Why?
|
| Fever | 2 | 2010 | 311 | 0.080 |
Why?
|
| Follow-Up Studies | 1 | 2019 | 5412 | 0.080 |
Why?
|
| Treatment Refusal | 1 | 2009 | 80 | 0.070 |
Why?
|
| Encephalitis, Viral | 1 | 2008 | 21 | 0.070 |
Why?
|
| Steroids | 1 | 2009 | 173 | 0.070 |
Why?
|
| Ultrasonography | 1 | 2013 | 988 | 0.070 |
Why?
|
| Enterovirus Infections | 1 | 2008 | 49 | 0.070 |
Why?
|
| Epstein-Barr Virus Infections | 1 | 2010 | 288 | 0.070 |
Why?
|
| Algorithms | 1 | 2014 | 1721 | 0.070 |
Why?
|
| Herpesvirus 4, Human | 1 | 2010 | 671 | 0.070 |
Why?
|
| Heart Failure | 1 | 2019 | 2390 | 0.060 |
Why?
|
| Brain Diseases | 1 | 2008 | 305 | 0.060 |
Why?
|
| Recurrence | 1 | 2009 | 1468 | 0.060 |
Why?
|
| Immunosuppressive Agents | 1 | 2009 | 672 | 0.060 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2013 | 2168 | 0.060 |
Why?
|
| Plasma Exchange | 1 | 2024 | 88 | 0.050 |
Why?
|
| Age Factors | 2 | 2020 | 2913 | 0.050 |
Why?
|
| Fibrinolysis | 1 | 2022 | 44 | 0.050 |
Why?
|
| Fibrin | 1 | 2022 | 64 | 0.050 |
Why?
|
| Prevalence | 1 | 2007 | 2658 | 0.040 |
Why?
|
| Case-Control Studies | 1 | 2007 | 3410 | 0.040 |
Why?
|
| Plasma | 1 | 2020 | 102 | 0.040 |
Why?
|
| Transfusion Reaction | 1 | 2019 | 39 | 0.040 |
Why?
|
| Cardiac Output | 1 | 2019 | 166 | 0.040 |
Why?
|
| Biomedical Research | 1 | 2024 | 553 | 0.040 |
Why?
|
| Cold Temperature | 1 | 2018 | 83 | 0.040 |
Why?
|
| Platelet Aggregation | 1 | 2018 | 107 | 0.030 |
Why?
|
| Anti-Bacterial Agents | 1 | 2009 | 2554 | 0.030 |
Why?
|
| In Vitro Techniques | 1 | 2018 | 862 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2020 | 1254 | 0.030 |
Why?
|
| Heart Rate | 1 | 2019 | 588 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2017 | 822 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 2019 | 1179 | 0.030 |
Why?
|
| Blood Platelets | 1 | 2018 | 320 | 0.030 |
Why?
|
| Socioeconomic Factors | 1 | 2018 | 902 | 0.030 |
Why?
|
| Blood Pressure | 1 | 2019 | 1400 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2022 | 3760 | 0.020 |
Why?
|
| Jaundice | 1 | 2010 | 27 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2020 | 3991 | 0.020 |
Why?
|
| India | 1 | 2008 | 238 | 0.020 |
Why?
|
| Abdominal Pain | 1 | 2010 | 314 | 0.020 |
Why?
|
| United States | 1 | 2023 | 11653 | 0.020 |
Why?
|
| Syndrome | 1 | 2008 | 1174 | 0.010 |
Why?
|
| Risk Factors | 1 | 2020 | 10941 | 0.010 |
Why?
|
| Pregnancy | 1 | 2017 | 7543 | 0.010 |
Why?
|
| Adult | 1 | 2024 | 31547 | 0.010 |
Why?
|